Jacques Galipeau, MD FRCP(C) President, ISCT Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health Cell and Gene Therapies (CGTs), especially at the intersection of gene-modified...
From the President’s Desk: Cell and Gene Therapies and air travel Closer than you think Jacques Galipeau, MD FRCP(C) President, ISCT Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of...
Jacques Galipeau, MD FRCP(C) ISCT President Don and Marilyn Anderson, Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health In 1968, a toddler with Wiscott-Aldrich syndrome – a lethal genetic bone marrow...
From the President’s Desk: Regionalism Adds Depth to the ISCT I nternational Vision Jacques Galipeau, MD FRCP(C) Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health The former...
From the President's Desk: Inaugural Letter By: Jacques Galipeau, MD FRCP(C) Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health You know cell & gene therapy (CGT) is in the...
From the President's Desk April 2022 Integration, Evolution, and Serendipity by: Bruce Levine, PhD President, ISCT United States Dear Colleagues and Friends, Hello and farewell from Philadelphia’s Cellicon Valley. As I’ve gathered my thoughts for these...
4 Comments - no search term matches found in comments.
Telegraft Hub - From the President’s Desk February 2022 by: Bruce Levine PhD President, ISCT United States Compose, Encode, Transmit, Receive, Decode, Interpret = Communication One of the most prominent hills in San Francisco is Telegraph Hill, which...